International Surgical Sleep Society Supports Hyoid Suspension for Effective Sleep Apnea Management

Hyoid Suspension Endorsed by International Surgical Sleep Society

Recent findings from the International Surgical Sleep Society (ISSS) have led to the endorsement of hyoid suspension as a viable treatment option for obstructive sleep apnea (OSA). This decision comes after an exhaustive review of clinical research demonstrating the efficacy and safety of this surgical approach. The position statement released by ISSS affirms that hyoid myotomy and suspension, either conducted alone or in conjunction with other procedures, are effective surgical interventions for adult patients suffering from mild to severe OSA.

A Proven Solution for Sleep Apnea

The Society has referenced decades of clinical studies highlighting the positive outcomes associated with hyoid suspension. A pivotal study conducted by Van Tassel et al. in 2021 showcased significant results from a series of 39 patients who underwent hyoid myotomy and suspension in combination with uvulopalatopharyngoplasty. This study reported that 76.9% of participants achieved surgical success, achieving an average Apnea-Hypopnea Index (AHI) reduction from 49.9 to 15.4, indicating a notable improvement in their condition.

AIRLIFT®: A Game-Changer in OSA Management

One of the leading innovations in this field is the AIRLIFT® system developed by Siesta Medical. AIRLIFT utilizes the Encore System to offer a less invasive and more effective method for hyoid suspension. According to Peter Martin, CEO of Siesta Medical, the AIRLIFT procedure provides a promising alternative for patients who have not responded to CPAP therapy or are unsuitable candidates for hypoglossal nerve stimulation. This technique counters previous challenges related to anatomical suitability, offering a more accessible solution for many patients.

The process involves repositioning the hyoid bone and securing it using two small implants and sutures, which enhances airway stability and reduces the risk of obstruction during sleep by managing muscle attachments effectively. In a comprehensive treatment strategy, patients undergoing the AIRLIFT hyoid suspension procedure on average see a 74% improvement in sleep apnea occurrences.

A Cost-Effective and User-Friendly Option

Beyond improving clinical outcomes, the AIRLIFT procedure is minimally invasive, well-tolerated by patients, and significantly more affordable compared to alternative surgical implants. This combination of effectiveness, cost-efficiency, and ease of implementation represents a substantial step forward in the surgical management of OSA.

Conclusion

The ISSS position statement fortifies the credibility and effectiveness of hyoid suspension in treating obstructive sleep apnea, marking a crucial advancement in the field of sleep medicine. Patients seeking alternatives to traditional treatments now have a promising option backed by solid clinical evidence. As interest in hyoid suspension grows, practitioners are encouraged to consider it as part of a multi-faceted treatment plan for their patients struggling with this debilitating condition. To learn more about the AIRLIFT system or access the complete ISSS position statement, visit Siesta Medical's official website.